Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Jase79on Aug 31, 2018 7:48am

94 Views

Post# 28547417

RE:RE:Sorry BJ

The media doesn’t care about a Canadian Start up that has been dragging Its feet for over 12 years.

They are interested In scientists who are working on cures and prevention, via the human genome. This science has advanced so rapidly. Patients can now be screened for cancers with just a blood sample, with a faster diagnosis.

Over the next couple years it will be interesting to see, how many cures the genome and gene therapy bring. Tlt could have have been a headliner 20 years ago. At this point it looks as if they’ve missed the bus.

Bullboard Posts

What is renewable energy's role in the future energy equation?